BCG vaccination
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
 | This article is a stub. |
Bacille Calmette-Guérin vaccination or BCG vaccination is a vaccination which been used to protest against tuberculosis (TB) for over 100 years. More recently, BCG vaccines have been found to cause more wide-ranging and positive immune system effects[1] and has been suggested as a treatment for Fibromyalgia[2] and COVID-19.[citation needed]
Theory
Evidence
Fibromyalgia clinical trial
A planned trial of three BCG vaccine doses for people with fibromyalgia was approved by the FDA but was withdrawn in 2022.[3]
Clinicians
Risks and safety
Cost and availability
Notable studies
- 2022, BCG vaccinations drive epigenetic changes to the human T cell receptor: Restored expression in type 1 diabetes[1] - (Full text)
- 2012, Unique immunologic patterns in fibromyalgia[2] - (Full text)
News and articles
- 2023, An Old TB Vaccine Might Help Stave Off Diabetes, Cancer Alzheimer's, and More - Scientific American
- 2021, An Old TB Vaccine Might Help Stave Off - STAT News
- 2020, Beyond Tuberculosis: BCG Vaccine and Epigenetics - CDC blog (archived copy)
- 2017, Century-Old Vaccine Gives New Hope To Fibromyalgia Community - ProHealth.com (archived copy)
See also
Learn more
- 2023, An Old TB Vaccine Might Help Stave Off Diabetes, Cancer Alzheimer's, and More - Scientific American
- 2021, An Old TB Vaccine Might Help Stave Off - STAT News
References
- ↑ 1.0 1.1 https://doi.org/10.1126%2Fsciadv.abq7240
- ↑ 2.0 2.1 http://www.biomedcentral.com/1472-6890/12/25
- ↑ Faustman, Denise Louise; Massachusetts General Hospital (April 5, 2022). "Phase II Clinical Trial: Multi-dosing the BCG Vaccine for Fibromyalgia". Clinical Trials. Retrieved March 4, 2023.
